Establishment of a mouse model of propylthiouracil‐induced antineutrophil cytoplasmic antibody‐associated vasculitis
Animal Models and Experimental Medicine · 2026-04 · 9 (4) · 822-828
DOI: 10.1002/ame2.70172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 09.03.2026. Verfasst von Sakiko Masuda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Sapporo, Japan. Hauptthemen laut MEDLINE: Propylthiouracil, Disease Models, Animal, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV) is a systemic autoimmune disease characterized by small‐vessel inflammation and the presence of ANCAs, which primarily target myeloperoxidase (MPO) and proteinase 3. Propylthiouracil (PTU), an antithyroid drug, is known as a causative drug of MPO‐AAV. PTU induces the formation of DNase I‐resistant neutrophil extracellular traps (NETs), which act as autoantigen sources and trigger the production of MPO‐ANCAs. Although a rat model of PTU‐induced AAV has been established, previous attempts to develop a corresponding mouse model have failed to replicate its histopathological features. In this study, we developed a novel murine model of PTU‐induced AAV by enhancing neutrophil recruitment through intraperitoneal injection of thioglycolate, followed by intraperitoneal administration of phorbol 12‐myristate 13‐acetate and PTU to induce DNase I‐resistant NETs. Freund's complete adjuvant was coadministered intradermally to amplify the immune response. This protocol resulted in abundant NET deposition in peritoneal tissues, elevated MPO‐ANCA levels, and the development of pauci‐immune glomerular lesions that closely resembled those observed in human AAV. Furthermore, a modified enzyme‐linked immunosorbent assay (ELISA) reliably quantified murine MPO‐ANCA levels. Thus, we established a novel murine model of PTU‐induced AAV that recapitulates both the serological and histopathological features of the human disease. This model provides a valuable platform for investigating disease mechanisms, including NETs‐ and ANCA‐mediated AAV pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Sapporo, Japan.
- Kidswell Bio Corporation, Tokyo, Japan.
- Department of Rheumatology, Endocrinology, and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
- Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Japan.
ORCID-Profile: Sakiko Masuda, Akihiro Ishizu
Zitieren
APA
Masuda, S., Uchizawa, M., Terasaka, C., Abe, T., Nakamura, T., Nishibata, Y., Ueda, Y., Nakazawa, D., Tomaru, U., & Ishizu, A. (2026). Establishment of a mouse model of propylthiouracil‐induced antineutrophil cytoplasmic antibody‐associated vasculitis. Animal Models and Experimental Medicine, 9(4), 822-828. https://doi.org/10.1002/ame2.70172
Vancouver
Masuda S, Uchizawa M, Terasaka C, Abe T, Nakamura T, Nishibata Y, et al. Establishment of a mouse model of propylthiouracil‐induced antineutrophil cytoplasmic antibody‐associated vasculitis. Animal Models and Experimental Medicine. 2026;9(4):822-828. doi:10.1002/ame2.70172
BibTeX
@article{Masuda2026,
author = {Masuda, Sakiko and Uchizawa, Momo and Terasaka, Chihiro and Abe, Takumi and Nakamura, Tetsuro and Nishibata, Yuka and Ueda, Yusho and Nakazawa, Daigo and Tomaru, Utano and Ishizu, Akihiro},
title = {Establishment of a mouse model of propylthiouracil‐induced antineutrophil cytoplasmic antibody‐associated vasculitis},
journal = {Animal Models and Experimental Medicine},
year = {2026},
volume = {9},
number = {4},
pages = {822--828},
doi = {10.1002/ame2.70172}
}
EUVIMED